Intrauterine Growth Restriction Clinical Trial
Official title:
Study of Placental Bed of Growth Restricted Fetuses: Correlation of Doppler Velocimetries of Uterine and Umbilical Arteries With Placental Pathology
When indicated, a conservative management plan of IUGR was undertaken. Doppler studies were
performed within the last week before delivery The results of Umbilical artery (UA) Doppler
velocimetry were categorized as normal , increased , absent, and reversed . Patients were
admitted for close surveillance in the case of worsening of maternal or fetal conditions
(e.g. absent or reversed UA blood flow, and severe preeclampsia).
Tissue samples The general shapes of placentas were assessed. The collected placentas were
weighed by trimming the membranes and umbilical cord. Then the diameters and thickness of
placentas were noted. The position of insertion of umbilical cord on the fetal surface of
placenta was observed. Transverse cuts were made through the maternal surface at a distance
of 1-2 cm in bread loaf manner and examined for the pale areas. All placentas were immersed
in 10% formalin overnight and examined on the next day. For each placenta, blocks containing
cord, membrane and full thickness of villous tissue were prepared. Whole thickness villous
tissue blocks were obtained from three zones, i)central zone ii) peripheral zone and iii)
intermediate zone between the first two zones, so as to include all areas of placenta.
Placental bed biopsies were obtained at Caesarean sections with direct visualization of the
placental site. Biopsies of at least 1cm were taken. The specimens were fixed in buffered
formalin. The tissues were processed and stained with Haematoxlyin and Eosin. Microscopic
study of placenta was carried out utilizing a set of standard criteria for villous and
intervillous lesions
Immunohistochemistry Expression of VEGF and CD34 was analyzed in 75 (50 placenta of IUGR and
25 of control) placental villous tissues.
Immunostaining was performed by the streptavidin-biotin-peroxidase method. Evaluation of
immunohistochemical staining To determine the MVD, the stained placental vasculature. Tissue
sections were initially screened microscopically at low power (100×) to identify the areas
of highest vascularization ("hot spots").
Evaluation of immunohistochemical staining of VEGF:
When indicated, a conservative management plan of IUGR was undertaken according to a defined
protocol including antenatal visits, ultrasound surveillance. The frequency of fetal
surveillance was assessed at each visit according to the maternal and fetal conditions.
Doppler studies were performed within the last week before delivery using a 3.5-Mhz
transducer, color-flow mapping, and a 50-Hz high-pass filter; all measurements were
performed with the mothers in a semi recumbent position. Color-flow imaging was used to
visualize the ascending branch of the uterine arteries. Pulsed Doppler velocimetry was
performed with a sample volume of 5 mm.
A minimum of three separate recordings was taken for each examination. The wave contour of
the uterine arteries was studied for the presence of a diastolic notch from which the
systolic/end-diastolic (S/ D) ratio was calculated. Abnormal uterine velocimetry was defined
as an average of (left and right) S/ D ratio and by the bilateral presence of diastolic
notching. Umbilical artery waveform was measured from free-floating loop of cord during
fetal quiescence. The pulsatility index (PI) (maximum velocity - minimum velocity/ mean
velocity) was calculated and the average of three measurements was used. An abnormal
umbilical artery PI was defined as standard deviations above the mean for gestational age
based reference standards (Chitty and Altman, 1999).
The results of Umbilical artery (UA) Doppler velocimetry were categorized as normal
(end-diastolic velocity <90th percentile of our reference curve), increased (end-diastolic
velocity ≥90th percentile), absent, and reversed (Madazil R et al., 2002) Patients were
admitted for close surveillance in the case of worsening of maternal or fetal conditions
(e.g. absent or reversed UA blood flow, and severe preeclampsia). Preeclampsia was defined
according to standard criteria (Arduini D et al, 2002).
Tissue samples The general shapes of placentas were assessed. The collected placentas were
weighed by trimming the membranes and umbilical cord. Then the diameters and thickness of
placentas were noted. The position of insertion of umbilical cord on the fetal surface of
placenta was observed. Transverse cuts were made through the maternal surface at a distance
of 1-2 cm in bread loaf manner and examined for the pale areas. All placentas were immersed
in 10% formalin overnight and examined on the next day. For each placenta, blocks containing
cord, membrane and full thickness of villous tissue were prepared. Whole thickness villous
tissue blocks were obtained from three zones, i)central zone ii) peripheral zone and iii)
intermediate zone between the first two zones, so as to include all areas of placenta.
Placental bed biopsies were obtained at Caesarean sections with direct visualization of the
placental site. Biopsies of at least 1cm were taken. The specimens were fixed in buffered
formalin. The tissues were processed and stained with Haematoxlyin and Eosin. Microscopic
study of placenta was carried out utilizing a set of standard criteria for villous and
intervillous lesions (Kotigwar S et al 2011). For studying these criteria 8 random
microscopic fields were chosen and 100 villi were counted in each field and studied for the
presence of following criteria:
1. Syncytial knots >30% in one field
2. Fibrinoid necrosis >5% in one field
3. Placental infarction >5% in one field Intervillous space
a) Chorangiosis b) Perivillous fibrinoid deposition >5% in one field c) Infarctions d)
Presence of calcification. e) Thickened hylinosed blood vessels For statistical purpose such
changes are labeled as "Abnormal placenta"
Immunohistochemistry Expression of VEGF and CD34 was analyzed in 75 (50 placenta of IUGR and
25 of control) placental villous tissues. Samples (1.5 × 1.5 × 1 cm in diameter) taken from
the maternal surface of each placenta; infarct areas were excluded from the study. All
tissues were fixed in formalin, embedded in paraffin, and cut into 5-μm-thick sections,
which were collected on slides coated with poly-L-lysine. After the paraffin was removed,
the sections were rehydrated.
Immunostaining was performed by the streptavidin-biotin-peroxidase method. Endogenous
peroxidase activity was blocked using 3% hydrogen peroxide. Antigen retrieval was carried
out in a microwave oven for 15 minutes in 10 nM citrate buffer (pH 6.0) for VEGF. The
sections were incubated at room temperature for one hour with EP1176Y rabbit polyclonal
antibodies reactive with VEGF (1:100; Genova, Spain), CD34 mouse monoclonal antibodies
Ventana. USA). After washing in phosphate-buffered saline with Tween-20, the tissues were
incubated with a biotin-conjugated secondary antibody and then with a biotin-streptavidin
complex for 30 min at room temperature. Reactions were visualized with 3,3-diaminobenzidine
tetrahydrochloride (DAB). Sections were counterstained with hematoxylin, rinsed, and
mounted.
Evaluation of immunohistochemical staining
Evaluation of immunohistochemical staining of CD34:
Microvessel Density Determination
The most popular method to study the angiogenic activity in a tissue is to count the number
of microvessels per unit area of tissue section, known as the microvessel density (MVD).
(Hasan J et al, 2002) To determine the MVD, the stained placental vasculature. Tissue
sections were initially screened microscopically at low power (100×) to identify the areas
of highest vascularization ("hot spots"). Five high-power (400×) fields were then chosen
randomly, and the number of microvessels in each high-power field (0.09 mm2) was counted for
each sample with the use of an ocular grid. MVD for each sample was taken as the mean of the
five values obtained. (Mustafa G et al, 2012)
Evaluation of immunohistochemical staining of VEGF:
The intensity and localization of the staining reaction in chorionic villous stromal cells,
vascular smooth muscle cells, villous vascular endothelial cells, cytotrophoblasts,
syncytiotrophoblasts, and extravillous trophoblasts was evaluated. Immunoreactivity for
antibodies was scored using a semi-quantitative scale for intensity of staining: 0 negative,
no staining; 1+ weak positive; 2+ moderately positive; 3+ strongly positive. (Barut F et al,
2010)
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04506970 -
Predicting Placental Pathologies by Ultrasound Imaging
|
||
Recruiting |
NCT03866863 -
Intra Uterine Growth Restriction
|
||
Recruiting |
NCT03662178 -
Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
|
||
Not yet recruiting |
NCT05720169 -
Fetal, Obstetrics and Reproduction Genomics
|
||
Completed |
NCT04633551 -
Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes
|
N/A | |
Recruiting |
NCT05500989 -
PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis
|
||
Recruiting |
NCT04141189 -
Comparison of Follow-up Protocols in Terms of Fetal, Neonatal and Maternal Results in Intrauterine Growth Retardation
|
N/A | |
Completed |
NCT03726697 -
Effect of Tahneek on Hypoglycemia in Newborn Infants
|
N/A | |
Recruiting |
NCT03398629 -
Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies
|
||
Recruiting |
NCT02473991 -
Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight
|
N/A | |
Completed |
NCT02696577 -
The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction
|
Phase 2 | |
Recruiting |
NCT04766866 -
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
|
N/A | |
Terminated |
NCT04047966 -
Study of the Fetal and Maternal Microbiota in Preganant Women With Fetal Defect Growth
|
||
Not yet recruiting |
NCT03865628 -
Ultrasound Evaluation of Fetal Hemodynamics and Perinatal Complications
|
||
Completed |
NCT05328453 -
Sonographic 3D Measurement of Fetal Thymus May be Used to Predict the Small Baby in Pregnancy.
|
||
Completed |
NCT05800938 -
The Effect of Oral Isosorbide Mononitrate Therapy on Umbilical Artery Doppler Resistance Index in Pregnancies With Intrauterine Growth Restriction: Prospective Randomized Control Trial
|
Phase 4 | |
Not yet recruiting |
NCT06226051 -
Growing Little PEAPODS Study
|
||
Recruiting |
NCT02807324 -
Women Specific Cardiac Recovery After Preeclampsia
|
||
Recruiting |
NCT02515292 -
Evaluation of Infants With Intrauterine Growth Restriction
|
N/A | |
Active, not recruiting |
NCT01942525 -
Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants
|
N/A |